Gyre Therapeutics, Inc. GYRE CA — Operating Loss Carryforwards

Similar metrics at other companies

TMCCA — Operating Loss Carryforwards

$54.68M+44.3%

NOVTCA — Operating Loss Carryforwards

$7.1M+9.2%

CGCCA — Operating Loss Carryforwards

$3.18B+0.7%

NBCA — Operating Loss Carryforwards

$53.19M+11.7%

BVCA — Operating Loss Carryforwards

$2.8M—

HAFCCA — Operating Loss Carryforwards

$131.4M0.0%

Questions, answered.

What is Gyre Therapeutics, Inc.'s CA — operating loss carryforwards?

Gyre Therapeutics, Inc. (GYRE) reported CA — operating loss carryforwards of $75.2M in Q1 2026.

How has Gyre Therapeutics, Inc.'s CA — operating loss carryforwards changed year-over-year?

Gyre Therapeutics, Inc.'s CA — operating loss carryforwards decreased by 0.0% year-over-year, from $75.2M to $75.2M.

What does CA — operating loss carryforwards mean?

Represents the cumulative amount of historical operating losses incurred within the California geographic segment that can be carried forward to offset future taxable income. This metric is critical for assessing the potential future tax shield available to the company as it scales its commercial operations. It reflects the historical investment phase of the business and the potential for reduced tax liabilities once the segment achieves sustained profitability.